Generic Abortion Pill Maker Sues FDA to Protect Access
- Lawsuit comes as Supreme Court poised to rule in Texas case
- GenBioPro makes most of the mifepristone sold in the US
Boxes of mifepristone manufactured by GenBioPro.
Photographer: Allen G. Breed/AP Photo
This article is for subscribers only.
A generic-mifepristone maker sued the US Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington.
The lawsuit by GenBioPro Inc., filed Wednesday in federal court in Maryland, comes as the US Supreme Court delayed until Friday a decision on which restrictions on the pill will remain in place after a federal judge in Texas blocked the FDA’s approval of mifepristone in a separate lawsuit.